SMAD4 and neoplasm: SCC is commonly associated with dysregulated TGFβ signaling, with 69% of human patients exhibiting TGFβRII downregulation and 35% exhibiting SMAD4 deletions in tumor epithelial cells, which is critical for canonical TGFβ signaling8,9.